Navigation Links
Imprivata Cortext Secure Text Messaging Solution Validated as HIPAA Compliant by ecfirst
Date:7/18/2013

patient care. This gave us confidence that Imprivata Cortext would satisfy both IT and clinical workflow requirements when we decided to introduce secure text messaging. As expected, our clinicians have been extremely impressed with the functionality and ease-of-use of Imprivata Cortext, which has improved productivity and enhanced patient care while maintaining compliance with HIPAA and privacy regulations. Imprivata is an integral partner in our long-term IT strategy because it develops solutions that are fast, secure and enable clinicians to focus on what matters most—delivering high-quality patient care."

Chuck Deckert, vice president, health information technology solutions with Sharp Community Medical Group in San Diego, Calif.
"Like many healthcare IT executives, we are constantly trying to balance convenience and ease-of-use with security and compliance requirements. Our clinicians were particularly frustrated by the inability to use text messaging to communicate and collaborate with one another, which prompted us to evaluate potential solutions. After considering several options, we elected to deploy Imprivata Cortext. The product is equipped with all the functionality to satisfy our clinicians’ needs for faster, more efficient communication. With the third-party HIPAA compliance evaluation now complete, we are also assured that private patient health information will remain secure as we roll out Imprivata Cortext on a larger scale."

Lynne Dunbrack, program director, Connected Health IT Strategies, IDC Health Insights
"Increasing demand amongst clinicians to use smartphones and other modern technologies presents a number of security and compliance challenges for healthcare organizations. Our research in this area highlights the need for solutions that remove the barrier to technology created by HIPAA and security requirements to provide care givers with the convenience they need to better communicate, col
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
2. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. MEDITECH Customers According to HIMSS Analytics
3. Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review
4. Arizona State University secures defense contract
5. OnPage Provides Secure, Rapid Response at New England’s Largest Catholic Hospital
6. Researchers develop secure protocol for linking data registries for HPV surveillance
7. TrueShred Partners With Virginia Commerce Bank To Host Shred Events and Securely Shred Documents and Files.
8. Two Participants in the Local Hero Van Giveaway Secure and Receive Wheelchair Accessible Vans with the Help of Superior Van and Mobility
9. Monitored Home Alarm System Quotes Now Available at SafeandSecureAlarm.com
10. What is HIPAA compliant Email? Health BI Reveals the Facts about HIPAA Secure Messaging
11. Sika Sarnafil Secures Factory Mutual Global Approval For Vegetated Roofing System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 On October ... Minds featuring skin diseases both fictional and real. ... (CEHMDF), a nonprofit organization committed to advocacy and philanthropy ... CBS will take the opportunity to impart truth and ... , There are many misconceptions about Morgellons ...
(Date:10/22/2014)... For Dr. Iris Hunter, a job is ... extension of her life’s mission. Her extensive experience in the ... of FirstLight HomeCare, make it clear that Hunter’s mission is ... my work makes a difference in the lives of others,” ... after much research, I felt ready to start on this ...
(Date:10/22/2014)... Kentucky (PRWEB) October 22, 2014 Shriners ... agreement that will change the current location of Shriners ... to South Limestone across from the University of Kentucky ... a state-of-the-art ambulatory care center, owned and operated by ... the orthopaedic needs of children and their families well ...
(Date:10/22/2014)... With the Affordable Care Act (ACA) open enrollment period starting ... Research (AIR) finds that three out of four Americans are ... percent say they are not likely or only somewhat likely ... , The AIR survey found wide gaps in Americans’ health ... how much they owe for a routine doctor’s visit. , ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Healthcare ... completing their continuing education at home or on-the-go ... access to 20 brand new, premium Seminar-on-Demand CE ... catalog of over 2,000 hours of ... customize their educational experience. With such a diverse ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2
... & Ellis Company on REIT,s Growth Strategies, SANTA ANA, ... announced that Scott D. Peters will continue to serve as,Chairman ... Grubb &,Ellis Healthcare REIT following his resignation as Chief Executive ... am excited to be able to devote a greater degree ...
... study finds , , FRIDAY, July 11 (HealthDay News) -- People ... taking beta blockers should be kept on those medications while ... they weren,t taking beta blockers already, most of them should ... a report in the July 15 issue of the ...
... $850 million in cuts, WASHINGTON, July 11 ... important benefits and pay more out of,pocket for ... Medicare,Advantage plan altogether under legislation approved this week ... would cut nearly $14 billion from the,Medicare Advantage ...
... alcohol use, or binge drinking, among college students in the ... That is one of the key findings from research conducted ... Alcohol Study (CAS), a landmark study that surveyed more than ... a new review that examines the findings from the CAS ...
... Funds dedicated to Nursing,Homes, NEW YORK, July 11 ... mixed results and promising signs among state,government efforts to ... report, only four states spent more than 50 percent ... and community,based services. In New York State, 74% of ...
... Four Dogs Die of Cancer ... 2 MAF Canine Cancer Campaign Seeking ... and lovers in the United,States view canine cancer as the greatest health ... of cancer. Cancer is the,number one cause of death in dogs over ...
Cached Medicine News:Health News:Scott D. Peters to Continue as Chairman and CEO of Grubb & Ellis Healthcare REIT 2Health News:Scott D. Peters to Continue as Chairman and CEO of Grubb & Ellis Healthcare REIT 3Health News:Beta Blockers Help Hospitalized Heart Failure Patients 2Health News:Pennsylvania Seniors' Medicare Advantage Benefits at Risk 2Health News:Binge drinking tied to conditions in the college environment 2Health News:Binge drinking tied to conditions in the college environment 3Health News:New AARP Report Finds Mixed Results Among State Governments' Efforts to Balance Long Term Care Services Under Medicaid 2Health News:New AARP Report Finds Mixed Results Among State Governments' Efforts to Balance Long Term Care Services Under Medicaid 3Health News:Canine Cancer #1 Fear of Dog Lovers; Web Exclusive By Morris Animal Foundation Provides News on Latest Breakthroughs - Crucial Facts for Dog Owners 2
(Date:10/22/2014)... AUSTIN, Texas , Oct. 22, 2014 ... announced they have entered into a license and ... to target cancers. PhosImmune possesses technology ... the surfaces of tumor cells in association with ... from proteins that play a role in malignancy, ...
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
(Date:10/20/2014)... , Oct. 20, 2014  Indianapolis interventional medical ... Toronto -based 3D visualization leader ... of Neurological Surgeons Annual Meeting that they have ... brain surgery. The collaboration is the first of ... to improve patient outcomes. NICO,s BrainPath® interventional access ...
Breaking Medicine Technology:Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5
... Pharmaceuticals, Inc., (NASDAQ: ACRX ) ("AcelRx"), a ... of innovative therapies for the treatment of acute and ... patent granted by the European Patent Office expired on ... that the patent has been opposed. The patent (European ...
... China, May 9, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ... a leading pharmaceutical company specializing in the development, manufacturing, ... announced today that the Company filed its annual report ... 2010 with the Securities and Exchange Commission on May ...
Cached Medicine Technology:AcelRx European Patent Covering its NanoTab® Sublingual Delivery Technology for Acute and Breakthrough Pain Pipeline Products Emerges From Opposition Period 2AcelRx European Patent Covering its NanoTab® Sublingual Delivery Technology for Acute and Breakthrough Pain Pipeline Products Emerges From Opposition Period 3
... system's curved-on-curved articulation maintains full inter-changeability. ... options for better patient fit. The ... spray porous coating, which offers an ... processed polyethylene is used for consistent, ...
... of posterior stabilized knee has an ... Patellar flange mates with both resurfacing ... assure precise, repeatable kinematics and fit ... to reduce wear. Constant cutting guide ...
... knee prosthesis stems from many years of ... manufacturing technologies have been used in order ... as a favorable pressure distribution pattern on ... to a minimum. The inherent design of ...
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
Medicine Products: